-
Electroencephalographic profile of children attending a neurophysiology centre in Lagos, Nigeria
Mohammed A Salisu, Idowu O Senbanjo
Research Article: Clinical Investigation
-
Electroencephalographic profile of children attending a neurophysiology centre in Lagos, Nigeria
Mohammed A Salisu, Idowu O Senbanjo
Research Article: Clinical Investigation
-
Electroencephalographic profile of children attending a neurophysiology centre in Lagos, Nigeria
Mohammed A Salisu, Idowu O Senbanjo
Research Article: Clinical Investigation
-
Electroencephalographic profile of children attending a neurophysiology centre in Lagos, Nigeria
Mohammed A Salisu, Idowu O Senbanjo
Research Article: Clinical Investigation
-
Electroencephalographic profile of children attending a neurophysiology centre in Lagos, Nigeria
Mohammed A Salisu, Idowu O Senbanjo
Research Article: Clinical Investigation
-
Electroencephalographic profile of children attending a neurophysiology centre in Lagos, Nigeria
Mohammed A Salisu, Idowu O Senbanjo
Research Article: Clinical Investigation
-
Electroencephalographic profile of children attending a neurophysiology centre in Lagos, Nigeria
Mohammed A Salisu, Idowu O Senbanjo
Research Article: Clinical Investigation
-
Electroencephalographic profile of children attending a neurophysiology centre in Lagos, Nigeria
Mohammed A Salisu, Idowu O Senbanjo
Research Article: Clinical Investigation
-
The therapeutic potential of glucagon-like peptide-1 analogs in the treatment of Alzheimers disease
Grazia D Femminella & Paul Edison
Editorial: Clinical Investigation
-
The therapeutic potential of glucagon-like peptide-1 analogs in the treatment of Alzheimers disease
Grazia D Femminella & Paul Edison
Editorial: Clinical Investigation
-
The therapeutic potential of glucagon-like peptide-1 analogs in the treatment of Alzheimers disease
Grazia D Femminella & Paul Edison
Editorial: Clinical Investigation
-
The therapeutic potential of glucagon-like peptide-1 analogs in the treatment of Alzheimers disease
Grazia D Femminella & Paul Edison
Editorial: Clinical Investigation
-
The therapeutic potential of glucagon-like peptide-1 analogs in the treatment of Alzheimers disease
Grazia D Femminella & Paul Edison
Editorial: Clinical Investigation
-
The therapeutic potential of glucagon-like peptide-1 analogs in the treatment of Alzheimers disease
Grazia D Femminella & Paul Edison
Editorial: Clinical Investigation
-
The therapeutic potential of glucagon-like peptide-1 analogs in the treatment of Alzheimers disease
Grazia D Femminella & Paul Edison
Editorial: Clinical Investigation
-
The therapeutic potential of glucagon-like peptide-1 analogs in the treatment of Alzheimers disease
Grazia D Femminella & Paul Edison
Editorial: Clinical Investigation
-
Clinical trials involving prisoners: a bioethical perspective
Kevin Knight, Patrick M Flynn
Editorial: Clinical Investigation
-
Clinical trials involving prisoners: a bioethical perspective
Kevin Knight, Patrick M Flynn
Editorial: Clinical Investigation
-
Clinical trials involving prisoners: a bioethical perspective
Kevin Knight, Patrick M Flynn
Editorial: Clinical Investigation
-
Clinical trials involving prisoners: a bioethical perspective
Kevin Knight, Patrick M Flynn
Editorial: Clinical Investigation
-
Clinical trials involving prisoners: a bioethical perspective
Kevin Knight, Patrick M Flynn
Editorial: Clinical Investigation
-
Clinical trials involving prisoners: a bioethical perspective
Kevin Knight, Patrick M Flynn
Editorial: Clinical Investigation
-
Clinical trials involving prisoners: a bioethical perspective
Kevin Knight, Patrick M Flynn
Editorial: Clinical Investigation
-
Clinical trials involving prisoners: a bioethical perspective
Kevin Knight, Patrick M Flynn
Editorial: Clinical Investigation
-
Clinical trials in older people: are we being ageist?
Peter Crome
Editorial: Clinical Investigation
-
Clinical trials in older people: are we being ageist?
Peter Crome
Editorial: Clinical Investigation
-
Clinical trials in older people: are we being ageist?
Peter Crome
Editorial: Clinical Investigation
-
Clinical trials in older people: are we being ageist?
Peter Crome
Editorial: Clinical Investigation
-
Clinical trials in older people: are we being ageist?
Peter Crome
Editorial: Clinical Investigation
-
Clinical trials in older people: are we being ageist?
Peter Crome
Editorial: Clinical Investigation
-
Clinical trials in older people: are we being ageist?
Peter Crome
Editorial: Clinical Investigation
-
Clinical trials in older people: are we being ageist?
Peter Crome
Editorial: Clinical Investigation
-
New-generation triazole antifungal drugs: review of the Phase II and III trials
Corrado Girmenia,Erica Finolezzi
Review Article: Clinical Investigation
-
New-generation triazole antifungal drugs: review of the Phase II and III trials
Corrado Girmenia,Erica Finolezzi
Review Article: Clinical Investigation
-
New-generation triazole antifungal drugs: review of the Phase II and III trials
Corrado Girmenia,Erica Finolezzi
Review Article: Clinical Investigation
-
New-generation triazole antifungal drugs: review of the Phase II and III trials
Corrado Girmenia,Erica Finolezzi
Review Article: Clinical Investigation
-
New-generation triazole antifungal drugs: review of the Phase II and III trials
Corrado Girmenia,Erica Finolezzi
Review Article: Clinical Investigation
-
New-generation triazole antifungal drugs: review of the Phase II and III trials
Corrado Girmenia,Erica Finolezzi
Review Article: Clinical Investigation
-
New-generation triazole antifungal drugs: review of the Phase II and III trials
Corrado Girmenia,Erica Finolezzi
Review Article: Clinical Investigation
-
New-generation triazole antifungal drugs: review of the Phase II and III trials
Corrado Girmenia,Erica Finolezzi
Review Article: Clinical Investigation